PBGENE-HBV

BIOLOGICAL2 trials

Sponsors

Precision BioSciences, Inc.

Conditions

Chronic HBV InfectionHEPATITIS B CHRONIC

Phase 1

Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B

RecruitingNCT06680232

Precision BioSciences, Inc.HEPATITIS B CHRONIC

Start: 2024-11-14End: 2027-06-01Target: 45Updated: 2026-08-24

Unknown Phase

A Long-term Observational Study in Participants Who Have Received PBGENE-HBV

Enrolling by invitationNCT07254208

Precision BioSciences, Inc.Chronic HBV Infection

Start: 2025-12-25End: 2040-06-01Target: 45Updated: 2026-04-22